Skip to main content
. 2021 Oct 18;16(6):823–838. doi: 10.1007/s11523-021-00831-4

Table 3.

Tool summarising the factors that permit to plan a TFR: in orange, the conditions where a TFR is either not recommended or hardly achievable; in yellow and green, the intermediate and best possible scenarios, respectively

graphic file with name 11523_2021_831_Tab3_HTML.jpg

DMR deep molecular response, TFR treatment-free remission, ELTS European Treatment and Outcome Study long‐term survival, MR molecular response, EMR early molecular response, TKI tyrosine-kinase inhibitor, IM imatinib mesylate, 2GTKI second-generation TKI